Skip to main content

Aravive, Inc.

ARAVDelisted Jan 29, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001513818

Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Aravive, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ARAV: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders3628−8
Shares5.54M3.97M−1.57M (−28.4%)
Value$5.47M$3.24M−$2.23M (−40.8%)

New holders (4)

Institutions that held Aravive, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ARAV in Q3 2022
InstitutionSharesValue% of portfolio
Verition Fund Management LLC25,000$20.0K0.00%
Jane Street Group, LLC11,323$9.00K0.00%
Royal Bank of Canada254$00.00%
Northwestern Mutual Wealth Management Co164$00.00%

Sold out (12)

Institutions that held Aravive, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of ARAV in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Armistice Capital, LLC1,316,129$1.30M
Dimensional Fund Advisors LP48,024$48.0K
Bluefin Capital Management, LLC28,785$29.0K
Bridgeway Capital Management, LLC22,625$22.0K
Two Sigma Investments, LP14,907$15.0K
Bank of New York Mellon Corp15,144$15.0K
Citadel Advisors LLC13,031$13.0K
Goldman Sachs Group Inc11,248$11.0K
FMR LLC2,500$2.00K
Newbridge Financial Services Group, Inc.841$1.00K
Simplex Trading, LLC31$0
Worth Asset Management, LLC120$0